TCT 2026
Powerful Medical will be on the exhibit floor. Visit our booth to see how AI ECG detection of occlusion myocardial infarction can shorten door-to-cath-lab times and get more patients to reperfusion faster.
San Diego, California, USA
October 31 – November 3, 2026
TCT is the annual scientific symposium of the Cardiovascular Research Foundation and the world's premier educational meeting in interventional cardiovascular medicine. Founded by Dr. Martin B. Leon in 1988 as a gathering of 150 people, it now attracts over 10,000 participants from more than 100 countries, with a faculty-heavy audience of interventional cardiologists, structural heart specialists, cath lab directors and cardiovascular surgeons.
The 38th annual TCT is themed around best clinical practices — the real-world application of evidence and innovation to individual patient decisions when the stakes are highest. Highlights include late-breaking clinical trials, expert-led tutorials, hands-on training, the TCT MedTech Innovation Forum and the TCT Shark Tank Innovation Competition.
- Venue: San Diego Convention Center, 111 W Harbor Drive, San Diego, California, USA
- Organiser: Cardiovascular Research Foundation (CRF)
- Website: tctconference.com
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.